Anemia is a common complication in post-lung transplant recipients. Although its mechanism is often multifactorial, clinicians should investigate an eventual underlying explanation to provide the best care. Among the reasons for anemia in lung transplant recipients, blood loss should be thought within the first few days after surgery. Later on, immune-mediated mechanisms, microangiopathic hemolytic anemia and reduction in red blood cell production mediated by viruses, drugs and infiltrative disorders prevail. This article reviews the mechanisms of anemia in post—lung transplant patients and provides an algorithm towards its approach.
References
1.
Nutritional anaemias.Report of a WHO scientific group. World Health Organ Tech Rep Ser1968; 405: 5-37.
2.
Tager AM, LC Ginns.Complications of lung transplantation. Crit Care Nurs Clin North Am1996; 8: 273-292.
3.
Vicente R., Morales P., Ramos F., Solé A., Mayo M., Villalain C.Perioperative complications of lung transplantation in patients with emphysema and fibrosis: experience from 1992-2002. Transplant Proc2006; 38: 2560-2562.
4.
Ferrer J., Roldan J., Roman A., et al. Acute and chronic pleural complications in lung transplantation . J Heart Lung Transplant2003; 22: 1217-1225.
5.
Bapat AR, Schuster SJ, Dahlke M., Ballas SKThrombocytopenia and autoimmune hemolytic anemia following renal transplantation . Transplantation1987; 44: 157-159.
6.
Salerno CT, Burdine J., Perry EH, Kshettry VR, Hertz MI, Bolman RM 3rd.Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation. Transplantation1998; 65: 261-264.
7.
Panaro F., DeChristopher PJ, Rondelli D., et al. Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant2004; 18: 332-335.
8.
Taaning E., Morling N., Mortensen SA, Pettersson G., Simonsen ACHemolytic anemia due to graft-derived anti-B production after lung transplantation . Transplant Proc1994; 26: 1739.
9.
Sokol RJ, Stamps R., Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion2002; 42: 198-204.
10.
Ramsey G.Red cell antibodies arising from solid organ transplants. Transfusion1991; 31: 76-86.
11.
McMillan MA , Muirhead CS, Lucie NP, Briggs JD, Junor BJAutoimmune haemolytic anaemia related to cyclosporin with ABO-compatible kidney donor and recipient. Nephrol Dial Transplant1991; 6: 57-59.
12.
Fabrega AJ, DeChristopher J., Sosler SD, Rivas PA, Vasquez EM, Pollak R.Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin. Clin Transplant1996; 10: 166-169.
13.
Riechsteiner G., Speich R., Schanz U., Russi EW, Weder W., Boehler A.Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon?Swiss Med Wkly2003; 133: 143-147.
Ramasubbu K. , Mullick T., Koo A., Hussein M., et al. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis2003; 5: 98-103.
16.
Franz M., Regele H., Schmaldienst S., Stummvoll HK, Hörl WH, Pohanka E.Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?Transplantation1998; 66: 1258-1262.
17.
Mach-Pascual S., Samii K., Beris P.Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am J Hematol1996 ; 52: 310-312.
18.
Rerolle JP, Akposso K., Lerolle N., et al. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. Clin Transplant2000; 14: 262-265.
19.
Cohen H., Bull HA, Seddon A., et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol1989; 43: 207-214.
20.
Lieberman KV, Lin WG, Reisman L.FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS). Transplant Proc1991; 23: 3119-3120.
21.
Moutabarrik A. , Ishibashi M., Fukunaga M., et al. FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells. Transpl Int1992; 5 Suppl 1: S93-S97.
22.
Reid DW, Street A., Mansfield D., et al. Microangiopathic haemolytic anaemia and thrombocytopenia following lung volume reduction surgery in a single lung transplant recipient on maintenance tacrolimus (FK506) therapy. Respirology2003 ; 8: 243-245.
23.
Myers JNShabshab SF, Burton NA, Nathan SDSuccessful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome. J Heart Lung Transplant1999; 18: 1024-1026.
24.
Ho DD, Rota TR, Andrews CA, Hirsch MSReplication of human cytomegalovirus in endothelial cells. J Infect Dis1984; 150: 956-957.
25.
Grefte JM, van der Giessen M., Blom N., The TH, van Son WJCirculating cytomegalovirus-infected endothelial cells after renal transplantation: possible clue to pathophysiology?Transplant Proc1995; 27: 939-942.
26.
Doherty M., Bradfield JWPolyarteritis nodosa associated with acute cytomegalovirus infection. Ann Rheum Dis1981; 40: 419-421.
27.
Murer L., Zacchello G., Bianchi D., et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol. 2000; 11: 1132-1137.
28.
Balfour HH Jr.Antiviral drugs. N Engl J Med1999; 340: 1255-1268.
29.
Geetha D., Zachary JB, Baldado HM, Kronz JD, Kraus ESPure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant2000; 14: 586-591.
30.
Baranski B. , Armstrong G., Truman JT, Quinnan GV Jr, Straus SE, Young NSEpstein-Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med1988; 109: 695-704.
31.
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med1994; 331: 1110-1115.
32.
Maheshwari A., Mishra R., Thuluvath PJPost-liver-transplant anemia: etiology and management. Liver Transpl2004; 10: 165-173.
33.
Apperley JF , Dowding C., Hibbin J., et al. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol1989; 17: 38-45.
34.
Eid AJ, Brown RA, Patel R., Razonable RRParvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis2006; 43: 40-48.
35.
Gottschalk S., Rooney CM, Heslop HEPost-transplant lymphoproliferative disorders . Annu Rev Med2005; 56: 29-44.
